Alamar Biosciences (ALMR) vs Bio-Rad Laboratories (BIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bio-Rad Laboratories is the larger company by market cap ($9.84 billion vs $1.93 billion), about 5.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | BIO |
|---|---|---|
| Share price | $27.77 | $367.92 |
| Market cap | $1.93B | $9.84B |
| 1-day change | -13.92% | -0.25% |
| YTD return | — | +21.43% |
| 1-year return | — | +24.08% |
| 5-year return | — | -49.00% |
| P/E ratio (TTM) | — | 46.63 |
| Forward P/E | — | 37.10 |
| EPS (TTM) | $-1.20 | $7.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $2.58B |
| Revenue growth (YoY) | — | +0.65% |
| Net income (latest FY) | — | $759.90M |
| Gross margin | — | 51.87% |
| Operating margin | — | 1.83% |
| Net margin | — | 29.42% |
| 52-week high | $39.61 | $396.23 |
| 52-week low | $18.85 | $236.73 |
| Distance from 52-week high | -29.89% | -7.14% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +27.48% | -10.76% |
| Average volume | 387.34K | 277.32K |
| Shares outstanding | 69.39M | 21.68M |
| Employees | 286 | 7,450 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bio-Rad Laboratories is about 5.1 times larger than Alamar Biosciences by market value ($9.84B vs $1.93B).
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About Bio-Rad Laboratories
BIO stock →Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 7,450 employees
ALMR vs BIO FAQ
Which is bigger, Alamar Biosciences or Bio-Rad Laboratories?
Bio-Rad Laboratories (BIO) is larger, with a market capitalization of $9.84B compared with $1.93B for Alamar Biosciences (ALMR).
Are Alamar Biosciences and Bio-Rad Laboratories in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.